IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 50.4

Change

-0.46 (-0.90)%

Market Cap

N/A

Volume

0.08M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

+0.65 (+0.44%)

USD 37.71B
FHLC Fidelity® MSCI Health Care In..

+0.11 (+0.16%)

USD 2.77B
FXH First Trust Health Care AlphaD..

-1.11 (-1.04%)

USD 1.05B
XHE SPDR® S&P Health Care Equipme..

-1.29 (-1.46%)

USD 0.20B
IDNA iShares Genomics Immunology an..

-0.58 (-2.58%)

USD 0.12B
SBIO ALPS Medical Breakthroughs ETF

-1.34 (-4.28%)

USD 0.09B
XHS SPDR® S&P Health Care Service..

-1.53 (-1.57%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.49 (-1.69%)

USD 0.05B
BBP Virtus LifeSci Biotech Product..

-2.27 (-3.68%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

-1.16 (-5.71%)

USD 6.67M

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 10.16 % 0.00 %

-0.40 (-1.42%)

USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.02% 62% D 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.02% 62% D 77% C+
Trailing 12 Months  
Capital Gain -4.66% 24% F 26% F
Dividend Return 0.78% 56% F 10% F
Total Return -3.88% 24% F 23% F
Trailing 5 Years  
Capital Gain 26.84% 52% F 58% F
Dividend Return 5.24% 58% F 13% F
Total Return 32.08% 52% F 51% F
Average Annual (5 Year Horizon)  
Capital Gain 4.86% 62% D 50% F
Dividend Return 5.51% 62% D 45% F
Total Return 0.65% 63% D 16% F
Risk Return Profile  
Volatility (Standard Deviation) 21.56% 43% F 50% F
Risk Adjusted Return 25.56% 57% F 39% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.